Duloxetine for Chronic Depression: a Double-Blind Study.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Duloxetine (Primary)
- Indications Depressive disorders; Dysthymic disorder
- Focus Therapeutic Use
- 02 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClincialTrials.gov.
- 09 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.